Sequoia backs Connect Medical Value and 10 more deal updates from Greater China Premium
Dermatology solutions provider Connect Medical Value (CMV) has secured “millions of US dollars” in its Series A round of financing led by Sequoia Capital China.
Lifescience-focused Hangzhou Wanlun Shangde Investment participated in the round as a new investor, per a company statement.
Early-stage healthcare investment firm Marathon Venture Partners made a follow-on investment in the round.
Proceeds from the latest round will be used to level up its digital healthcare management platform, and to enhance its talent pool.
Connect Medical Value, also known as Yongliu Technology, uses AI to develop skin disease-based digital healthcare management platforms and solutions.
streetAsia s premium subscription service Unlock your competitive advantage in a rapidly evolving landscape. Our packages come with exclusive access to archive content, data, discount on summit tickets & more. Be a part of our growing community now. SUBSCRIBE NOW
Singapore Reporter/s
In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digi
AnchorDx Completes USD 40 Million Series C Financing to Advance Cancer Screening and Early Detection Programs
News provided by
Share this article
Share this article
GUANGZHOU, China, Feb. 22, 2021 /PRNewswire/ AnchorDx Medical Co., Ltd. ( AnchorDx ) announced the completion of a USD 40 million Series C financing. This round of financing was jointly led by OrbiMed, a world-renowned biomedicine and healthcare venture capital fund, and WuXi Huiying Investment, an investment fund focusing on the health and wellness industry. To date, AnchorDx has successfully attracted well-known investors including the top biopharmaceutical and medical diagnosis companies Wuxi AppTec and KingMed Diagnostics, as well as leading investment funds such as Northern Light Venture Capital, 6 Dimensions Capital, Serica Jianxin Venture Capital, Arch Venture Partners, Marathon Venture Partners, OrbiMed, and WuXi Huiying Investment.